Sartorius Aktiengesellschaft (ETR:SRT3)
Germany
· Delayed Price · Currency is EUR | Market Cap | 13.24B |
| Revenue (ttm) | 3.55B |
| Net Income (ttm) | 162.60M |
| Shares Out | 69.04M |
| EPS (ttm) | n/a |
| PE Ratio | 81.41 |
| Forward PE | 54.05 |
| Dividend | 0.74 (0.34%) |
| Ex-Dividend Date | Mar 27, 2026 |
| Volume | 114,383 |
| Average Volume | 107,165 |
| Open | 215.00 |
| Previous Close | 218.80 |
| Day's Range | 212.70 - 220.50 |
| 52-Week Range | 175.95 - 267.70 |
| Beta | 1.45 |
| RSI | 43.49 |
| Earnings Date | Apr 23, 2026 |
About ETR:SRT3
Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers analytical solutions, such as biolayer interferometry systems, high-throughput screening by cytometry systems, process analytical technology and data analytics, cell selection and retrieval, live-cell imaging and analysis systems, and surface plasmon resonance systems; cell culture solutions, including bioreactors and fermenters, cell culture reagents, supplements and matrices, nucleic acid and delivery solutions, cell culture... [Read more]
Financial Performance
In 2025, ETR:SRT3's revenue was 3.54 billion, an increase of 4.66% compared to the previous year's 3.38 billion. Earnings were 154.90 million, an increase of 84.40%.
Financial StatementsNews
Sartorius AG (SSSGY) Q1 2026 Earnings Call Highlights: Strong Start with Robust Sales Growth ...
Sartorius AG (SSSGY) Q1 2026 Earnings Call Highlights: Strong Start with Robust Sales Growth and Strategic Innovations
Q1 2026 Sartorius AG and Sartorius Stedim Biotech SA Earnings Call Transcript
Q1 2026 Sartorius AG and Sartorius Stedim Biotech SA Earnings Call Transcript
Sartorius Aktiengesellschaft Earnings Call Transcript: Q1 2026
Q1 2026 saw robust sales and recurring business growth, resilient margins, and strong cash flow, with guidance for 5%-9% sales growth and EBITDA margin above 30% for the year. Equipment sales are expected to improve, and FX and geopolitical risks are being managed.
Sartorius Aktiengesellschaft (SARTF) Reports Q1 Earnings with Positive Outlook
Sartorius Aktiengesellschaft (SARTF) Reports Q1 Earnings with Positive Outlook
Sartorius AG Q1 Sales Increase
BRUSSELS (dpa-AFX) - Sartorius AG (SARTF) revealed earnings for first quarter of EUR56.2 millionThe company's bottom line came in at EUR56.2 million, or EUR1.20 per share. This compares with EUR48...
Sartorius Q1 Underlying Net Profit Declines; Confirms 2026 Guidance
(RTTNews) - Sartorius (SRT3.DE, SRT.DE) reported first quarter net profit of 56.2 million euros compared to 48.5 million euros, prior year. Underlying EBITDA was up slightly by 1.6 percent to 267 mill...
Sartorius Aktiengesellschaft Transcript: AGM 2026
AGM highlighted strong 2025 financial results, strategic acquisitions, and investments in innovation and sustainability. Leadership changes and refined strategy focus on portfolio, customer experience, and operational excellence. Dividend of EUR 0.73/0.74 per share proposed.
Sartorius Aktiengesellschaft Transcript: CMD 2026
The event outlined a strategy focused on innovation, operational excellence, and customer experience, targeting 8%-11% group growth and 50-75 bps annual EBITDA margin expansion. Key growth drivers include single-use technologies, advanced therapies, and digitalization, with normalization expected by 2027.
Sartorius Aktiengesellschaft Earnings Call Transcript: Q4 2025
2025 saw strong recurring revenue growth, margin expansion, and improved leverage, with results exceeding guidance. 2026 guidance anticipates 5%-9% sales growth, margin above 30%, and continued investment in innovation and capacity, amid ongoing market normalization and volatility.
It's time to scoop up undervalued stocks in this critical sector of the economy
Expanding your horizons and considering neglected sectors can help you identify bargain opportunities while defending your investment portfolio from a stock-market decline.
Sartorius Aktiengesellschaft Earnings Call Transcript: Q3 2025
Sales grew 7.5% in constant currencies, led by strong consumables demand and margin expansion. Guidance for 2025 was specified, with group sales expected to rise 7% and EBITDA margin above 29.5%. Equipment demand remains subdued, but gradual recovery is anticipated.
Sartorius Shares Rise After Guidance Lift
Sartorius said it now expects 7% revenue growth for 2025, compared with 6% previously, as underlying net profit rose 17%.
Sartorius Aktiengesellschaft Earnings Call Transcript: Q2 2025
H1 2025 delivered 6% revenue growth and 12% EBITDA growth, led by strong consumables demand, while equipment sales lagged. Guidance for 2025 is confirmed, with continued margin expansion and deleveraging, despite FX and tariff headwinds.
Sartorius Aktiengesellschaft Earnings Call Transcript: Q1 2025
Q1 2025 delivered strong sales and margin growth, led by consumables, while equipment demand stayed soft. Guidance for 2025 is robust, with 6% sales growth and 29%-30% EBITDA margin targeted. The MatTek acquisition and regulatory shifts support innovation and future growth.
Sartorius Aktiengesellschaft Transcript: AGM 2025
The AGM highlighted stable revenues, strong order growth, and continued profitability despite market volatility. Leadership transitions were announced, with a new CEO set for July 2025. Strategic investments, innovation, and sustainability remain key priorities.
Sartorius Aktiengesellschaft Earnings Call Transcript: Q4 2024
2024 results met revised guidance with robust profitability and strong order intake in consumables, while equipment sales remained weak. Free cash flow doubled, leverage improved, and 2025 is expected to bring moderate, profitable growth above market rates, with continued focus on efficiency and deleveraging.
Betting on Growth: 4 Favorite Stocks From T. Rowe Price's Peter Bates
The manager of the Global Select Equity Strategy looks for high margins, cash generation, competitive advantages, and a long runway of growth.
Sartorius Aktiengesellschaft Earnings Call Transcript: Q3 2024
Nine-month 2024 results met expectations, with robust recurring sales and strong order intake, especially in consumables, offsetting weak equipment demand. Profitability and cash flow improved, guidance for the year is confirmed, and efficiency programs are set to deliver further benefits in Q4.
Sartorius Aktiengesellschaft Earnings Call Transcript: Q2 2024
H1 results met targets but sales and margins declined year-over-year amid ongoing market volatility and weak demand, especially for equipment. Guidance for 2024 was lowered to flat sales with a focus on efficiency gains, while long-term fundamentals remain positive.
Sartorius Aktiengesellschaft Transcript: CMD 2024
Sartorius Aktiengesellschaft Earnings Call Transcript: Q1 2024
Sartorius Aktiengesellschaft Transcript: AGM 2024
Sartorius Aktiengesellschaft Earnings Call Transcript: Q4 2023
10 stocks for investors looking for ‘wonderful companies at a fair price'
As money managers talk about various methods of selecting quality companies, investors might also think about diversification, which can lower risk and broaden opportunities.
These 5 DAX index companies are in trouble as their stocks plunge
German stocks are not doing well as the economy goes through substantial challenges. The most recent data showed that business confidence has tumbled while manufacturing and services PMIs have remaine...